Wegovy 2.4mg Pen (9.6mg TOTAL) [Semaglutide Injection]

Wegovy (Semaglutide) 2.4mg/dose is a GLP-1 receptor agonist prefilled pen designed for advanced metabolic and endocrine research. It is studied for its influence on energy expenditure, appetite regulation, and glucose control in non-clinical models.

Researchers value this compound for its selective GLP-1 receptor activity, stable pharmacokinetics, and controlled delivery system, making it an ideal research tool for examining incretin-based pathways.

Each prefilled pen delivers 2.4mg of semaglutide in a sterile, precision-calibrated formulation. All pens are produced to Canadian pharmaceutical grade standards, securely packaged, and verified through third-party analysis for purity and consistency.